A physiotherapy protocol based on the preferences of the individual with Parkinson disease for the health empowerment
Not Applicable
Recruiting
- Conditions
- Parkinson disease.C10.228.140.079.862.500
- Registration Number
- RBR-7zbxq5
- Lead Sponsor
- niversidade do Estado de Santa Catarina
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Diagnosis of Parkinson's disease; stages I through IV according to the Scale of HOEHN and YAHR; individuals correctly performing the drug treatment.
Exclusion Criteria
Individuals unable to practice physical exercises; Serious cognitive alterations; contraindication to any of the outcome tests.
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Expected outcome 1: Protocol viability. verified by the safety variables, (percentage of the occurrence of serious imbalances that compromise the safety of the participants during the intervention, being considered as parameter a limit of percentage of occurrences); adherence to the treatment, (attendance frequency of the participants to the treatment sessions, being considered as parameter the minimum percentage for each participant).This outcome will be assessed shortly after the participants' compliance with the eligibility criteria after completion of the 8 weeks of intervention and after 4 weeks of follow-up.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie patient preference-based physiotherapy in Parkinson disease management?
How does patient-centered physiotherapy compare to conventional approaches in improving motor and non-motor symptoms of Parkinson disease?
Are there specific biomarkers that predict response to individualized physiotherapy interventions in Parkinson disease patients?
What adverse events are associated with patient preference-based physiotherapy protocols for Parkinson disease and how are they managed?
What combination therapies or drug targets synergize with physiotherapy in addressing Parkinson disease symptoms?